NYSE · Surgical & Medical Instruments & Apparatus
Boston Scientific Corporation (BSX)
Boston Scientific's next earnings date, recent SEC filings, insider trades and reported financials, with end-of-day prices. Every number carries its date and source.
Last close
$44.12
+0.47% 1 day−55.0% 52 weeks
As of Sep 28, 2026, end of day (IEX). Not a live quote.
BSX · one year of daily closes
Sep 25, 2025 to Sep 28, 2026 · end of day · IEX
Closing prices, split-adjusted, from trades on the IEX exchange (published the next trading day). Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Key facts
- 1-day change
- +0.47%
- From $43.92 the session before
- 52-week change
- −55.0%
- Close vs close ~252 sessions earlier
- 52-week range
- $42.63–$105.02
- Lowest and highest closing prices
- Market cap
- $63.9B
- Last close × shares outstanding (SEC)
- Revenue (TTM)
- $21.0B
- 12 months to Jun 30, 2026
- Net income (TTM)
- $3.7B
- 12 months to Jun 30, 2026
- Diluted EPS (TTM)
- $2.47
- 12 months to Jun 30, 2026
Financials: trailing twelve months from Boston Scientific’s reported US-GAAP figures, SEC EDGAR XBRL company facts, period ended Jun 30, 2026.
Recent SEC filings
- Sep 23, 20268-KCurrent report: Executive or director change
- Sep 8, 20268-KCurrent report: Material cybersecurity incident
- Aug 26, 20268-KCurrent report: Other events
- Aug 3, 202610-QQuarterly report for the period ended Jun 30, 2026
- Jul 29, 20268-KCurrent report: Earnings results
- Jul 27, 20268-KCurrent report: Exit or disposal costs
- May 18, 20268-KCurrent report: Other events
- May 18, 20268-KCurrent report: Other events
Source: SEC EDGAR. Each line is written from the form type and the official 8-K item titles; open the filing for the full text. All BSX filings on EDGAR
Next earnings
~Oct 21, 2026Estimated
Past results were usually filed before the open
Estimated from past filing dates. Boston Scientific hasn't announced this date; Vero projects it from the rhythm of its past SEC filings, so treat it as approximate.
Insider activity (last 90 days)
- Open-market buys
- 5
- filings · 196,562 shares
- Open-market sales
- 0
- filings · 0 shares
- Morano Susan EDirectorFiled Aug 26, 2026Purchase 2,040at $49.22 avg
- Habiger David CDirectorFiled Aug 7, 2026Purchase 2,100at $47.59 avg
- Habiger David CDirectorFiled Aug 5, 2026Purchase 1,182at $48.13 avg
- Mahoney Michael FChairman, President & CEO, DirectorFiled Aug 5, 2026Purchase 186,240at $48.33 avg
- LUDWIG EDWARD JDirectorFiled Aug 3, 2026Purchase 5,000at $45.48 avg
Source: SEC EDGAR Form 4, filed in the 90 days to Oct 1, 2026. Counts are filings with at least one open-market purchase (P) or sale (S); grants, option exercises, tax withholding and gifts are left out.
Insider share counts and prices are as reported on Form 4.
With a free Vero account
What Vero tracks about Boston Scientific
Each new Boston Scientific filing and headline, summarized in plain English and scored 1–10 for how much it matters. Write down why you own BSX, and Vero reads every new item against those reasons: confirms, challenges or breaks. Alerts say when something crosses the line you set.
Boston Scientific (BSX): questions, answered from the data
When is Boston Scientific's next earnings date?
What was BSX's last closing price?
Have Boston Scientific insiders bought or sold shares recently?
What did Boston Scientific file with the SEC most recently?
Is this page a recommendation to buy or sell BSX?
Related by SEC industry code
- SYKStryker Corporation$275.50+1.13%
- COHRCoherent Corp.$282.40−4.52%
- DHRDanaher Corporation$227.34+1.23%
- ILMNIllumina, Inc.$272.07+0.74%
- ISRGIntuitive Surgical, Inc.$414.86+2.40%
- KLACKLA Corporation$189.22+0.69%
Closes are end of day (IEX), as of each page’s date. Grouped by SEC industry code (SIC).
Prices: IEX HIST end-of-day bars, published the next trading day; never live. Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Filings, Form 4 and financials: Source: SEC EDGAR. Earnings dates: Vero’s calendar, marked confirmed or estimated.
Vero is a research tool, not a financial adviser. Nothing on this site is financial advice or a recommendation to buy or sell any security.
Data as of Oct 1, 2026.